FDA Admits Cannabis Fails Old Medical-Value Test as DEA Hearing Sharpens Rescheduling Fight
The second day of the Drug Enforcement Administration's administrative hearing on cannabis rescheduling turned confrontational in the most substantive way possible: opponents of marijuana reform
TerrAscend Acquires Option on Fifth New Jersey Dispensary in $9 Million Deal
TerrAscend Corp. has signed an option agreement to purchase Aunt Mary's Dispensary LLC, a single-location operation in Flemington, New Jersey, for a total of $9 million - extending the multi-state
A Minnesota Dispensary Owner Survives a Brutal Year to Land Full Adult-Use Licensure
After more than a year of operating at the edge of insolvency, Steven Rosenfeldt finally received a state adult-use cannabis license in January for Rosebuds Cannabis Co., his dispensary at 2223 U.S.
Congressional Bid to Block Cannabis Rescheduling Finds Little Support on Capitol Hill
A formal administrative hearing on the Trump administration's marijuana rescheduling proposal opened this week, and the most direct congressional threat to the process - a funding rider that would
Madrid's Live Music Surge Raises Real Questions for Cannabis Retail Event Strategy
Madrid is running one of the densest live entertainment schedules in recent European memory, with major touring acts, multi-day festivals, and residency-style stadium runs stacking up from July
DEA Shuts Pro-Rescheduling Voices Out of Its Own Cannabis Hearing
The Drug Enforcement Administration has structured its upcoming administrative law judge hearing on cannabis rescheduling in a way that is, to put it plainly, unprecedented: seven anti-rescheduling
Legal Cannabis Sales Drop for the First Time, Taking 12,500 Jobs With Them
US legal cannabis retail has recorded its first year-over-year revenue decline since adult-use sales began in 2014. National revenue fell 3.3% to $29.1 billion, and the industry shed roughly 12,500
Canada's Hemp Trade Group Pushes to Rewrite Regulations From the Ground Up
The Canadian Hemp Trade Alliance has submitted a sweeping set of recommendations to Health Canada that would, if adopted, represent the most significant overhaul of Canada's industrial hemp
Glass House Brands Restructures to Pursue NYSE Listing, Splitting Cannabis Operations
Glass House Brands has applied to list its subordinate voting shares on the New York Stock Exchange - a move that required the California-based cannabis company to execute a significant structural
Israeli Cannabis Company Expands Into U.S. Genetics and German Markets Through Botanico Deal
InterCure Ltd., the Nasdaq- and Tel Aviv-listed medical cannabis company, has closed the first tranche of its acquisition of Botanico Ltd. - known commercially as ISHI - an Israeli cannabis